Bausch Health tumbles on unconfirmed report of bankruptcy
** U.S.-listed shares of drugmaker Bausch Health Companies
BHC.TO fall ~21.6% to $5.94
** According to analysts, data analytics agency Reorg
reported that BHC was negotiating a potential prepackaged
Chapter 11 bankruptcy filing
** Bausch in a statement says it has not been involved in
discussions with its creditors regarding bankruptcy proceedings
** Reuters could not independently verify the report
** Including session's move, BHC stock down 26% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on Bausch Health Companies
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data